Abstract
Successful pregnancy is the result of a delicate balance between fetal demands and maternal supply. The feto-maternal interface is the no man’s land for this dialogue. Immune cells set the rules of the feto-maternal cross talk, pipeline development, cell functions, and reactions to unexpected third parties. A dynamic and coordinate modification of number, morphology, function, and distribution of any type of inflammatory cells sustains the normal evolution of pregnancy and eventually helps to bring it to parturition. Abnormalities in the equilibrium of the inflammatory microenvironment can lead to placental histological lesions and adverse pregnancy outcome. Beyond acute infections, chronic villitis, chronic chorioamnionitis, chronic intervillositis, and chronic deciduitis often coexist as a tetrad, suggesting an abnormal immune response. Maternal characteristics such as visceral obesity could set the ground for the development of these placental lesions.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
1 Introduction
Pregnancy is a biologic example of a successful semi-allogenic graft: at the feto-maternal interface, the semi-allogenic embryonic cells that adhere and “dig” into the decidua are protected from maternal immune rejection. The feto-maternal interface is localized between the maternal uterine mucosa and the trophoblastic cells [1].
Maternal decidua does not represent a passive tissue in which blastocyst implants and develops its placenta. Maternal tissues not only do not reject trophoblastic cells but play an active role to support the placental development and function: the endometrium undergoes a specialized tissue reaction called decidualization whereby cell morphology, cell activity, gene expression, and immune cell distribution contribute to support the blastocyst apposition, adhesion, and implantation within the decidua [2].
The placenta originates from the extraembryonic portion of the polar zone of the blastocyst that adheres to the uterus during the implantation process. From the adhesion process of the blastocyst to the uterine decidua, the trophoblastic tissue undergoes a series of differentiations to develop into its final aspect of villi composed of stromal tissue containing fetal vessels and surrounded by trophoblastic cells: cyto- and syncytiotrophoblast, the inner and outer villous trophoblastic layers, respectively [3]. Meanwhile, a specific type of villi, called anchoring villi, permits to anchor the placenta to the decidua, by means of cytotrophoblast cells, named trophoblastic anchoring columns. Some of these trophoblastic cells detach from the columns and migrate through the decidual stroma, reach the spiral arteries, penetrate the wall of the maternal vessels, and colonize the lumen of the spiral arteries. This ignites the complex and essential process of vascular remodeling of spiral arteries. Maternal inflammatory cells now start to work against their natural mission and tolerate and accept this invasion of these extravillous, semi-allogenic, trophoblastic cells.
A cross talk between trophoblast and decidua is a fundamental prerequisite to maintain maternal immune tolerance toward the semi-allogenic embryo and to allow trophoblast invasion, placental development, and pregnancy evolution. This cross talk includes the expression of immune cells, dynamically dependent on the pregnancy progression [4]:
-
The first trimester of pregnancy is a phase of physiological inflammation [5]: leucocytes not only tolerate pregnancy but also they support gestation [6]. Immune cells in the first trimester are mainly natural killer (NK) cells (about 70 %) and macrophages (about 20 %), whereas the number of T cells is variable (about 10–20 %) and dendritic cells, B cells, and regulatory T cells are rare [7] (Fig. 4.1).
-
The second trimester of pregnancy is a phase of predominant anti-inflammatory state. In this time frame, the mother and fetus are in symbiosis and the fetus undergoes rapid development and growth [5].
-
The late third trimester of pregnancy is a phase characterized by a reconversion to a pro-inflammatory condition that characterizes human parturition of an altricial newborn [5].
2 Natural Killer Cells
In pregnancy, decidual natural killer cells have a characteristic and specific phenotype (CD56BRIGHT, CD16−, CD3−). They change their structure as pregnancy progresses to adapt themselves to the role of pregnancy supporters.
During the first trimester, NK cells contain specific granules rich in angiogenic growth factor and vascular endothelial growth factor C. Moreover, during the first stage of pregnancy, decidual NK cells secrete matrix metalloproteinases MMP2 and MMP9. These enzymes break down the extracellular matrix. This process directly helps trophoblast migration and invasion. At this stage, NK cells play a decisive role for the proper placental development, promoting spiral artery remodeling. The number and the function of uterine NK cells are crucial for the physiological evolution of pregnancy. Their abnormalities have been associated with implantation failure [8], miscarriage [9], preeclampsia, and fetal growth restriction [10].
In the second trimester, decidual NK cells undergo a degranulation process. This will stop the production of angiogenic and vascular growth factors. Interferon-γ (INF- γ) secretion starts to oppose vascular development. During the third trimester, the uterine NK cells in the decidua are degranulated. In this stage, their production of INF-γ inhibits the trophoblastic invasiveness, protecting the uterus from a too deep trophoblastic migration [6].
3 Macrophages
At the feto-maternal interface, macrophages represent the second most abundant leukocyte population within the human decidua. Commonly, macrophages are classified in two different types: M1, the proinflammatory type, and M2, the immune-regulatory type [11]. The type of decidual macrophages appears to be predominantly M2 [12]. Their function is that of immune suppression, scavenging of apoptotic cells, clearing cellular debris, and promoting tissue remodeling.
3.1 Decidual Macrophages
Decidual macrophages are maternal cells and protect human pregnancy throughout gestation by inhibiting the immune response by decidual NK, T lymphocytes, and other circulatory macrophages [6]. Thanks to their additional production of matrix metalloproteinases 9 and vascular endothelial growth factor, decidual macrophages are believed to play a role in the spiral artery remodeling [12]. Despite this role in spiral artery modification, the association between abnormal number or function of decidual macrophages and preeclampsia is controversial [7].
3.2 Placental Macrophages
Placental macrophages, also called “Hofbauer cells,” are CD68+ fetal cells early detectable in pregnancy in the villous stroma. Since Hofbauer cells appear in the placental villi prior to the appearance of the fetal circulation, they may originate in the early stage of pregnancy from progenitor cells within the population of mesenchymal cells in the villous stroma; then, later in pregnancy, they may originate from penetration of embryonic bone marrow-derived monocytes into the villous stroma [3]. Generally, macrophages intervene in phagocytosis of apoptotic bodies and cellular debris as well as antigen presentation in response to inflammation and infectious insults; the specific role of placental macrophages has not been fully understood yet [13]. Their close contact with endothelial progenitor cells and primitive vessels suggests that Hofbauer cells intervene in early placental vascular genesis [14]. Moreover, the identification of proteins regulating branching morphogenesis localized to Hofbauer cells permits to hypothesize a role of placental macrophages in the development of the placental villous tree [15]. Alterations in the number and aspect of Hofbauer cells may be associated with complications of pregnancy such as fetal immune or nonimmune hydrops and fetal metabolic storage diseases such as GM1 gangliosidosis, glucuronidase deficiency, and type VII mucopolysaccharidosis [13]. Histological features of elevated concentration of Hofbauer cells have been related to adverse pregnancy outcome in association with villitis of unknown etiology or acute chorioamnionitis (see below) [13].
4 T Cells
T cells are poorly represented within the human decidua. Their role is not completely understood.
During the early stages of pregnancy, a successful implantation occurs in a finely regulated pro-inflammatory/anti-inflammatory microenvironment; T cells seem to play a crucial role in this balance. T-helper (Th) cells can be classified into Th1 cells, which are involved in cellular immunity, and Th2 cells, which are involved in humoral immunity [16]. In the past, maternal tolerance of the semi-allogenic graft was explained by an absolute predominance of the Th2-type immunity, which overrules Th1-type immunity, therefore protecting the fetus from maternal Th1-cell attack [17]. More recently, the role of Th1 has been reconsidered, showing that Th1 activity plays an important role in pregnancy, promoting Th2 response, regulating the placentation process, defending the maternal–fetal microenvironment against infections, and later cooperating in the initiation of delivery [18]; therefore, the concept of absolute Th2 predominance has been reconsidered and the hypothesis of “Th1–Th2 cooperation” has been introduced [18]. Moreover, it has been suggested that differences in the expression of the Th1 pro-inflammatory action and Th2 anti-inflammatory action depend on the phase of pregnancy: early and late pregnancy needs a Th1 milieu, whereas Th2 cells prevail in mid gestation (Table 4.1) [5]. Abnormal pregnancy outcome may occur in the presence of an aberrant Th1/Th2 profile: an excessive Th1 reaction may be associated with recurrent miscarriage, preterm delivery, and preeclampsia [18, 19], but even an increase of Th2 secretion at the feto-maternal interface could be associated with miscarriage and preeclampsia [18].
Histological features of placental elevated concentration of T cells have been associated with adverse pregnancy outcome as may occur in chronic deciduitis, chronic chorioamnionitis, and villitis of unknown etiology [7] (see below).
4.1 T Regulatory Cells
T regulatory cells (Treg) are a subset of T lymphocytes that act as strong suppressors of inflammatory immune response with a fundamental role in preventing destructive immune response and auto-inflammatory and autoimmune disease, warranting peripheral self-tolerance and immune homeostasis [20, 21]. Treg cells levels are high in maternal blood during the first and second trimesters of pregnancy and decline prior to delivery and postpartum [20]. Moreover, Treg cells physiologically accumulate in the maternal decidua. A deficiency in Treg cells number has been associated with recurrent miscarriage and preeclampsia [20]. Indeed, it is of interest to underline that there are two developmental pathways of Tregs: thymic (tTreg) and extrathymic or peripheral (pTreg). tTregs appear to suppress autoimmunity, whereas pTregs operate to downregulate responses to antigens, such as those from ingested food, symbiotic bacteria, and allergens. Genomic analysis allowed to hypothesize that pTregs emerged in eutherian (placental) mammals to protect from maternal–fetal conflict. As a matter of fact, conserved noncoding sequence 1 (CNS1), which is required for pTreg development, has been detected present in all placental mammals, whereas it is absent in non-placental mammals such as the wallaby, opossum, and platypus, as it is expected to be absent in non-mammals such as zebra fish. pTregs specifically sort out paternal antigens in the trophoblastic cells and suppress effector T cells in an active process to induce tolerance [22]. Figure 4.2 shows the quasi-perfect correspondence between wild-type pregnant mice and knocked-out ones as regards embryonic reabsorption and number of females that presents reabsorbed embryos [23].
5 Dendritic Cells
Dendritic cells (DCs) are at the biological bridge between the innate and the adaptive immune system and their activation and modulation is critical for the outcome of the immune response. DCs localize in the peripheral tissue and act as sentinel of the immune response. After an inflammatory stimulus, DCs migrate via lymphatic vessels to the lymph node to present antigen to T cells [7]. According to their state (activated or not activated), DCs can secrete pro- or anti-inflammatory cytokines, thereby inducing immune responses or suppressing them, respectively.
In pregnancy, the number of DCs in the decidua is very low and the cells are phenotypically immature. The role of decidual DCs has not been fully elucidated; recently, it was suggested that DCs, as well NKs and macrophages, could act at the feto-maternal interface, intervening in the tissue remodeling and promoting maternal immune tolerance [7]. An increased number of phenotypically mature DCs have been associated with spontaneous miscarriage [24].
6 B Cells
B cells are a component of the humoral immunity of the acquired immune system. The main function of B cells is the production of antibodies (IgG, IgM, IgE, IgA), but B cells can also uptake, process, and present antigens and can produce several cytokines influencing immunity. The role of B cells during pregnancy has been poorly studied, but it was postulated that they may contribute toward pregnancy tolerance by regulating the production of the immune-modulatory cytokine IL-10 [25]. A physiological decrease of B cells was noted in the third trimester of normal pregnancy while preeclampsia has been associated with a persistence of a higher number of B cells. In women with autoimmune disease, it is possible that B cells compromise gestation, producing excessive autoantibodies [25].
7 Trophoblast as Regulator of Innate Immune Cell
Trophoblastic cells express pattern recognition receptors that act as “sensors” of the surrounding microenvironment [5]. These sensors allow the recognition of the presence of bacteria, viruses, damaged tissues, and dying cells by the trophoblast. Trophoblastic cells can secrete a specific set of cytokines influencing the immune cells within the decidua with the aim of instructing inflammatory cells to create an adequate microenvironment, to promote pregnancy evolution [5]. The success of the pregnancy depends on the trophoblastic ability to communicate with any immune cell type (monocytes/macrophages, pTreg and NK cells) and to coordinate their interrelated work [5, 26].
8 The Alteration of the Maternal–Fetal Equilibrium of the Inflammatory Cells
Alterations in type, number, aspect, or interrelationship of any component of the cells of the inflammatory milieu may be detrimental for pregnancy outcome. This might be the consequence of infections or of maternal immunological problems, either in clinical or in subclinical conditions.
Infection can reach the placenta and the fetus through the maternal blood circulation or by ascending into the uterus from the vagina or by descending into the uterus from the peritoneal cavity, by activation of the pathogenic phenotype of preexisting bacteria, or even by sudden immune reaction toward preexisting symbiotic bacteria.
8.1 Acute Chorioamnionitis
These processes could develop into acute chorioamnionitis. In these cases, most of infecting agents originate in the cervicovaginal tract and gain access to the uterine cavity breaching the normal cervical barrier. Maternal neutrophils infiltrate the chorionic plate and membranous chorioamnion (Fig. 4.3) [27]. Normally, neutrophils are a population of inflammatory cells that do not infiltrate placental compartments. When an infective insult occurs, neutrophils can invade placental structures; they can derive both from the intervillous space and the venules of decidua capsularis. In case of acute chorioamnionitis, a maternal and/or a fetal inflammatory response should be distinguished. The stage (progression of the disease) and the grade (intensity of the disease) of the inflammatory response are summarized in Table 4.2. Acute chorioamnionitis has been associated with adverse pregnancy and neonatal outcome, in relation to prematurity due to preterm delivery and/or preterm premature rupture of the membrane [29]. Fetal inflammatory response is the main factor that affected fetal–neonatal well-being; fetal inflammatory response involves chorionic plate vessels and/or umbilical vein prior to the involving of umbilical arteries. The association between fetal inflammatory response and adverse neonatal condition and outcome takes place especially when umbilical arteries are involved. Neonatal sepsis could be a consequence of fetal inflammatory response but also neurological impairment may develop including cerebral palsy [30].
When fetal neutrophils are found in fetal capillaries and stroma of distal villi, with minimal intervillous component, the lesion is called acute villitis and it could represent an expression of intrauterine fetal sepsis due to a bacterial hematogenous infection such as Escherichia coli or group B streptococcus.
8.2 Chronic Chorioamnionitis
The differential diagnosis of acute chorioamnionitis includes chronic chorioamnionitis, a placental lesion characterized by an infiltration of maternally derived T lymphocytes CD3+ in the chorioamniotic membranes [27]. Viral infection can be associated with chronic chorioamnionitis, but the actual cause of this lesion is still unknown. A frequent association between chronic chorioamnionitis and villitis of unknown etiology and the altered chemokine profile observed in the amniotic fluid of cases affected by chronic chorioamnionitis permit to hypothesize an immunological cause of this histological placental lesion, suggesting a reaction consistent in maternal anti-fetal rejection [31, 32]. Chronic chorioamnionitis has been associated with spontaneous preterm birth and intrauterine fetal growth restriction [27].
8.3 Chronic Villitis of Unknown Etiology
Chronic villitis of unknown etiology is a placental lesion characterized by the presence of villous mononuclear cell infiltrates composed of maternal CD8+ T lymphocytes [33]. An increased number of placental Hofbauer cells may coexist and a histiocytic infiltrate within the intervillous space (chronic intervillositis) may accompany the chronic villitis. The origin of this lesion is still unknown but a maternal immune response against the fetus has been advocated, similar to host-versus-graft rejection [33]. Although a low grade of villitis of unknown etiology could affect placentas from normal pregnancies without clinical consequences, high-grade lesions could be associated with severe abnormal pregnancy outcome. Clinical associations are summarized in Table 4.3. Recurrent villitis in the subsequent pregnancies is associated with maternal obesity (a known condition of immune dysfunction) and multigravidity (in relation to the repeated exposure to the fetal antigens).
8.4 Chronic Villitis in Oocyte Donation
Pregnancies derived from donated oocyte also present a high prevalence of villitis of unknown etiology. Egg donation pregnancies represent an interesting challenge for the feto-maternal interface immunological aspect: the mother must tolerate a completely allogenic conceptus. The higher incidence of villitis of unknown etiology, as well as other placental histological lesions (chronic deciduitis, massive chronic intervillositis, increased infiltration of T-helper cells, and natural killer cells), in the basal plate of egg donation pregnancies seems to be related to a more pronounced immune-mediated response in this particular type of medical achieved pregnancies. The placental histological damages and the frequently abnormal clinical evolution of egg donor pregnancies may be the consequence of a reaction similar to graft-versus-host disease and/or organ rejection [34].
8.5 Chronic Deciduitis
Chronic deciduitis corresponds to a mixed lymphoplasmacytic infiltrate in the decidua, identifiable either in the free membrane or along the maternal surface, sometimes encroaching the anchoring villi. The presence of plasma cells in the endometrium is always considered an abnormal feature (Fig. 4.4). It may develop as a consequence of antigen-stimulating events related both to infection and noninfection insults [35]. A source of antigen is bacterial subacute endometritis that may cause recurrent acute chorioamnionitis and preterm delivery in the subsequent pregnancies [36]; otherwise, an alloimmune response may be at the base of chronic deciduitis. When there is not an acute inflammation, decidual plasma cells are associated with infertility, miscarriage, and chronic villitis [28].
In summary, an acute neutrophilic infiltrate of the placenta is generally related to infective insults, as occurs in acute chorioamnionitis; a chronic placental inflammatory infiltrate (including lymphocytes, histiocytes, plasma cells) generally represents an inflammatory noninfective placental reaction, as occurs in chronic villitis, chronic chorioamnionitis, chronic intervillositis, and chronic deciduitis. These four last lesions often coexist as a tetrad, suggesting an alloimmune response. Maternal characteristics such as obesity and autoimmune disease (including systemic lupus erythematosus, antiphospholipid syndrome, type 1 diabetes mellitus, and thyroiditis) could constitute a predisposing factor for the development of these placental damaging lesions.
Schematic exemplification of the distribution of the inflammatory cell during the placental lesions is shown in Fig. 4.5
9 Inflammatory Lesions of the Decidua
Annetine Staff defines the decidua basalis “the decidual battleground” [37]. This is the place, the no man’s land, where all these cells rush, live, cooperate, and fight in human reproduction. A more subtle immune-inflammatory lesion that dramatically impacts on placental function in late gestation is acute atherosis. This lesion affects 20–40 % of cases of late preeclampsia but is observed also as a minor lesion in a subset of “normal” pregnancies, suggesting a continuum of unbalanced interaction from subclinical to clinical to severe disease. This local process occurs without systemic vascular lesions. Histologically acute atherosis is characterized by CD68-positive subendothelial lipid-filled foam cells. These cells derive macrophages and possibly smooth muscle cells. This process is associated with an infiltration of inflammatory mononuclear cell like early stages of atherosclerosis in coronary artery disease. This lesion is seldom seen in the myometrial tract of spiral arteries and is not caused by hypertension. This process is immune-inflammatory in nature and not caused by dyslipidemia. It might be observed in pregnancies with fetal growth restriction and immune diseases. It is of interest to observe that this lesion might be found not only in abnormal spiral arteries as per early shallow trophoblastic invasion but also and mainly in normal spiral arteries. Atherosis ignites a vicious circle of under-perfusion, oxidative stress, inflammation, and atherosis. According to Staff and coworkers [38], the hyperlipidemia of normal pregnancy worsens in women with a pro-atherogenic lipid profile that develop preeclampsia.
These recent findings suggest a possible link between low-grade inflammation, dyslipidemia that characterize metabolic syndrome and excess, and/or severity of late gestation acute atherosis and late preeclampsia, associated with a normal fetal growth.
The full understanding of these pathological concepts should induce clinical counselors to underline the importance of prepregnancy lifestyle and nutrition for a successful pregnancy.
References
Red-Horse K, Zhou Y, Genbacev O, Prakobphol A, Foulk R, McMaster M, Fisher SJ. Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface. J Clin Invest. 2004;114(6):744–54.
Gellersen B, Brosens IA, Brosens JJ. Decidualization of the human endometrium: mechanisms, functions, and clinical perspectives. Semin Reprod Med. 2007;25(6):445–53.
Huppertz B. The anatomy of the normal placenta. J Clin Pathol. 2008;61(12):1296–302.
Oreshkova T, Dimitrov R, Mourdjeva M. A cross-talk of decidual stromal cells, trophoblast, and immune cells: a prerequisite for the success of pregnancy. Am J Reprod Immunol. 2012;68:366–73.
Mor G. Inflammation and pregnancy. The role of toll-like receptors I trophoblast-immune interaction. Ann N Y Acad Sci. 2008;1127:121–8.
Rapacz-Leonard A, Dąbrowska M, Janowski T. Major histocompatibility complex I mediates immunological tolerance of the trophoblast during pregnancy and may mediate rejection during parturition. Mediators Inflamm. 2014;2014:821530.
Erlebacher A. Immunology of the maternal-fetal interface. Ann Rev Immunol. 2013;31:387–411.
Tuckerman E, Mariee N, Prakash A, Li TC, Laird S. Uterine natural killer cells in peri-implantation endometrium from women with repeated implantation failure after IVF. J Reprod Immunol. 2010;87:60–6.
Quenby S, Bates M, Doig T, Brewster J, Lewis-Jones DI, Johnson PM, Vince G. Pre-implantation endometrial leukocytes in women with recurrent miscarriage. Hum Reprod. 1999;14:2386–91.
Williams PJ, Bulmer JN, Searle RF, Innes BA, Robson SC. Altered decidual leucocyte populations in the placental bed in pre-eclampsia and foetal growth restriction: a comparison with late normal pregnancy. Reproduction. 2009;138:177–84.
Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004;25:677–86.
Gustafsson C, Mjösberg J, Matussek A, Geffers R, Matthiesen L, Berg G, Sharma S, Buer J, Ernerudh J. Gene expression profiling of human decidual macrophages: evidence for immunosuppressive phenotype. PLoS One. 2008;3:e2078.
Tang Z, Abrahams VM, Mor G, Guller S. Placental Hofbauer cells and complications of pregnancy. Ann N Y Acad Sci. 2011;1221:103–8.
Seval Y, Korgun ET, Demir R. Hofbauer cells in early human placenta: possible implications in vasculogenesis and angiogenesis. Placenta. 2007;28:841–5.
Anteby EY, et al. Human placental Hofbauer cells express sprouty proteins: a possible modulating mechanism of villous branching. Placenta. 2005;26:476–83.
Saito S, Nakashima A, Shima T, Ito M. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am J Reprod Immunol. 2010;63:601–10.
Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today. 1993;14:353–6.
Wilczynski JR. Th1/Th2 cytokines balance – yin and yang of reproductive immunology. Eur J Obstet Gynecol Reprod Biol. 2005;122:136–43.
Sykes L, MacIntyre DA, Yap XJ, Teoh TG, Bennett PR. The Th1:th2 dichotomy of pregnancy and preterm labour. Mediators Inflamm. 2012;2012:967629. doi: 10.1155/2012/967629. Epub 2012 Jun 7. Review. PMID: 22719180
Guerin LR, Prins JR, Robertson SA. Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment? Hum Reprod Update. 2009;15:517–35.
La Rocca C, Carbone F, Longobardi S, Matarese G. The immunology of pregnancy: regulatory T cells control maternal immune tolerance toward the fetus. Immunol Lett. 2014;162:41–8.
Williams Z. Inducing tolerance to pregnancy. N Engl J Med. 2012;367:1159–61.
Samstein RM, Josefowicz SZ, Arvey A, Treuting PM, Rudensky AY. Extrathymic generation of regulatory T cells in placental mammals mitigates maternal-fetal conflict. Cell. 2012;150:29–38.
Askelund K, Liddell HS, Zanderigo AM, Fernando NS, Khong TY, Stone PR, et al. CD83(+) dendritic cells in the decidua of women with recurrent miscarriage and normal pregnancy. Placenta. 2004;25:140–5.
Fettke F, Schumacher A, Costa SD, Zenclussen AC. B cells: the old new players in reproductive immunology. Front Immunol. 2014;5:285.
Fest S, Aldo PB, Abrahams VM, Visintin I, Alvero A, Chen R, Chavez SL, Romero R, Mor G. Trophoblast-macrophage interactions: a regulatory network for the protection of pregnancy. Am J Reprod Immunol. 2007;57:55–66.
Kraus FT, Redline R, Gersell DJ, Nelson DM, Dicke JM. Atlas of nontumor pathology: placental pathology. First series. Fascicle 3. Washington DC: American Registry of Pathology; 2004.
Redline RW, Faye-Petersen O, Heller D, Qureshi F, Savell V, Vogler C, Society for Pediatric Pathology, Perinatal Section, Amniotic Fluid Infection Nosology Committee. Amniotic infection syndrome: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol. 2003;6(5):435–48.
Goldenberg RL, Andrews WW, Hauth JC. Choriodecidual infection and preterm birth. Nutr Rev. 2002;60:S19–25.
Shatrov JG, Birch SC, Lam LT, Quinlivan JA, McIntyre S, Mendz GL. Chorioamnionitis and cerebral palsy: a meta-analysis. Obstet Gynecol. 2010;116:387–92.
Oggé G, Romero R, Lee DC, Gotsch F, Than NG, Lee J, Chaiworapongsa T, Dong Z, Mittal P, Hassan SS, Kim CJ. Chronic chorioamnionitis displays distinct alterations of the amniotic fluid proteome. J Pathol. 2011;223:553–65.
Redline RW. Villitis of unknown etiology: noninfectious chronic villitis in the placenta. Hum Pathol. 2007;38:1439–46.
van der Hoorn ML, Lashley EE, Bianchi DW, Claas FH, Schonkeren CM, Scherjon SA. Clinical and immunologic aspects of egg donation pregnancies: a systematic review. Hum Reprod Update. 2010;16:704–12.
Katzman PJ. Chronic inflammatory lesions of the placenta. Semin Perinatol. 2015;39:20–6.
Goldenberg R, Hautth J, Andrews W. Intrauterine infection and preterm delivery. N Engl J Med. 2000;342:1500–7.
Staff AC, Redman CW. IFPA Award in Placentology Lecture: preeclampsia, the decidual battleground and future maternal cardiovascular disease. Placenta. 2014;35:S26–31. doi: 10.1016/j.placenta.2013.12.003. Epub 2013 Dec 18. PMID: 24411701
Staff AC, Dechend R, Pijnenborg R. Learning from the placenta: acute atherosis and vascular remodeling in preeclampsia-novel aspects for atherosclerosis and future cardiovascular health. Hypertension. 2010;56:1026e34.
Kim CJ, Romero R, Kusanovic JP, Yoo W, Dong Z, Topping V, Gotsch F, Yoon BH, Chi JG, Kim JS. The frequency, clinical significance, and pathological features of chronic chorioamnionitis: a lesion associated with spontaneous preterm birth. Mod Pathol. 2010;23:1000–11.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Bulfamante, G.P., Avagliano, L. (2015). Pathology of the Placenta: A Continuum Spectrum of Inflammation from Physiology to Disease. In: Ferrazzi, E., Sears, B. (eds) Metabolic Syndrome and Complications of Pregnancy. Springer, Cham. https://doi.org/10.1007/978-3-319-16853-1_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-16853-1_4
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-16852-4
Online ISBN: 978-3-319-16853-1
eBook Packages: MedicineMedicine (R0)